Home page | Association for Accessible Medicines
Register Now - Next Steps Workshop to explore the science, manufacturing & quality components of generics + biosimilars.
  • Capitol Hill Briefing
    Patient Access to Affordable Medicines: How a Renegotiated NAFTA Could Keep Drug Prices High
  • Next Steps: Manufacturing and Quality Workshop
    Join AAM and USP in this workshop, which explores the science, manufacturing and quality components of generics and biosimilars.
  • Patients Can See Their Savings
    For the first time ever, the Association for Accessible Medicines is releasing savings data for 20 common patient conditions.
  • Preserve Patient Access in Trade Agreements
    Extending monopolies for brand-name drugs in trade agreements only increases patient drug prices. How? The new NAFTA deal decreases drug price competition.
  • New Report
    The 10th edition of the Generic Drug Access & Savings in the United States report.
  • Skyrocketing Drug Prices Are a Threat to Everyone
    Skyrocketing Drug Prices Are a Threat to Everyone
    Use this infographic to learn how generics and biosimilars are a remedy to sky-high health care costs.

Working to leave a positive impact on...

About Us

The Association for Accessible Medicines, formerly the Generic Pharmaceutical Association, improves access to safe, quality, effective medicine. Better access to medicine is relevant to everybody because, after all, we’re all patients at some point.

Health is the foundation for everything in life. Healthy people are better able to reach their full potential. Generics and biosimilars help more people in more places live healthier and longer.

Who We Are

Association for Accessible Medicines


Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.